Gardner D L, Cowdry R W
Psychopharmacol Bull. 1989;25(4):515-23.
Pharmacotherapy has emerged as a beneficial adjunct to psychotherapy in the overall treatment regimen for patients with borderline personality disorder. The authors review controlled and uncontrolled studies of neuroleptics, antidepressants, anxiolytics, anticonvulsants, and lithium carbonate in the treatment of this disorder. Although no one medication has emerged as the treatment of choice, patterns of response can be identified. These patterns may be helpful in guiding clinical choice of pharmacotherapy as well as directing research to an understanding of the etiological mechanisms underlying this complex disorder.
在边缘型人格障碍患者的整体治疗方案中，药物治疗已成为心理治疗的有益辅助手段。作者回顾了抗精神病药、抗抑郁药、抗焦虑药、抗惊厥药和碳酸锂治疗该障碍的对照研究和非对照研究。尽管尚未有一种药物成为首选治疗药物，但可以确定反应模式。这些模式可能有助于指导药物治疗的临床选择，以及引导研究去理解这种复杂障碍背后的病因机制。
